NovaDigm Therapeutics

The first vaccine to demonstrate efficacy in reducing the mortality of otherwise highly lethal bloodstream infections due to either Candida or S. aure....

Get a Demo and See the Full Profile

Get a demo today to see profiles of NovaDigm Therapeutics plus 5767 other startups.

Get A Demo

Learn More About NovaDigm Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Companies We Work With